Incyte Corporation
INCY
$119.52
-$3.47-2.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.82B | 5.36B | 5.14B | 4.81B | 4.58B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.82B | 5.36B | 5.14B | 4.81B | 4.58B |
| Cost of Revenue | 2.58B | 2.53B | 2.42B | 2.26B | 2.31B |
| Gross Profit | 3.24B | 2.83B | 2.72B | 2.56B | 2.28B |
| SG&A Expenses | 1.40B | 1.37B | 1.37B | 1.33B | 1.31B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.98B | 3.91B | 3.79B | 3.58B | 3.62B |
| Operating Income | 1.84B | 1.45B | 1.35B | 1.23B | 966.47M |
| Income Before Tax | 1.97B | 1.77B | 1.66B | 1.59B | 1.26B |
| Income Tax Expenses | 354.98M | 342.08M | 377.80M | 399.65M | 391.58M |
| Earnings from Continuing Operations | 1.61K | 1.43K | 1.29K | 1.19K | 870.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.61B | 1.43B | 1.29B | 1.19B | 870.87M |
| EBIT | 1.84B | 1.45B | 1.35B | 1.23B | 966.47M |
| EBITDA | 1.94B | 1.55B | 1.44B | 1.32B | 1.06B |
| EPS Basic | 8.13 | 7.29 | 6.59 | 6.11 | 4.50 |
| Normalized Basic EPS | 6.25 | 5.04 | 4.70 | 4.31 | 3.46 |
| EPS Diluted | 7.85 | 7.08 | 6.41 | 5.97 | 4.40 |
| Normalized Diluted EPS | 6.04 | 4.88 | 4.57 | 4.20 | 3.39 |
| Average Basic Shares Outstanding | 792.83M | 786.45M | 780.82M | 776.53M | 773.49M |
| Average Diluted Shares Outstanding | 821.24M | 811.77M | 803.14M | 795.79M | 790.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |